HBC Amgen Lecture Series: Lecture 7 - Choosing a Modality 


Wednesday, May 1, 2019, 5:00pm to 6:00pm


Building C - Cannon Room

"The Biotechnology Edge”

Insights from Lab Bench to Patient Bedside


May 1st, 2019
5:00 - 6:00pm
Cannon Room, HMS

Food will be provided!


Choosing a Modality
We will introduce Amgen’s broad toolkit of drug modalities and describe how we choose the “right” modality for drug discovery, focusing on biologic medicines.

Speaker: Hao Chen, PhD
Hao is a Principal Scientist in Biologics at Amgen.  He started his industrial career at Amgen in 2006 as a scientist in the structure biology group and currently is a group leader in Protein Technologies, Biologics.  Hao’s work is focused on enabling and accelerating the Amgen discovery research including small molecule and biologics therapeutic programs by utilizing cutting-edge protein engineering and protein production technologies.